Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | 0.00% | -1.80% | +10.08% |
Apr. 23 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
Apr. 16 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.